BIDMC researchers define immune system’s requirements for protection against COVID-19
Findings are important for vaccines, therapeutics and public health strategies to combat the COVID-19 pandemic. Read here
This author has not written his bio yet.
But we are proud to say that Morgana Souza contributed 243 entries already.
Findings are important for vaccines, therapeutics and public health strategies to combat the COVID-19 pandemic. Read here
Approval of early vaccines will make researching future ones very difficult. Read article
A new monkey study offers a ray of hope for speeding up clinical trials of Covid-19 vaccines. Read Article
A new study in monkeys suggests that a blood test could predict the effectiveness of a coronavirus vaccine — and perhaps speed up the clinical trials needed to get a […]
Our very own, Dr. Barouch, was selected as part of the Bloomberg 50. Read here
This study is assessing antibodies for the prevention of SARS CoV-2 infection of asymptomatic healthy adults.
Dr. Katy Stephenson speaks to Five Thirty Eight Podcast about vaccine safety and how it is monitor. Listen Here
Pfizer’s success creates an ethical dilemma for other clinical trials. Read Article
Dr. Stephenson clarifies why these results are noteworthy. Read Article
Dr. Barouch talks to the Bloomberg about many ways the body responds to infections/viruses. Read Article

3 Blackfan Circle
Boston, MA 02115 – USA
T 617.667.7000
F 617.735.4566
E CVVRcontact@bidmc.harvard.edu
T 617.735.4610
E CVVRtrials@bidmc.harvard.edu
[DISPLAY_ULTIMATE_SOCIAL_ICONS]
